Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
New England Journal of Medicine · 19.09.2024 · 391 (11) · 1002-1014
DOI: 10.1056/nejmoa2401537 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 19.09.2024. Verfasst von Daniel Wolff und 23 weiteren Autor:innen. Beteiligte Einrichtung: From University Hospital Regensburg, Regensburg, Germany (D.W.); Dana-Farber Cancer Institute and Harvard Medical School (C.C.) and Massachusetts Gen…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Receptor, Macrophage Colony-Stimulating Factor. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From University Hospital Regensburg, Regensburg, Germany (D.W.); Dana-Farber Cancer Institute and Harvard Medical School (C.C.) and Massachusetts General Hospital (Z.D.), Boston, and Syndax Pharmaceuticals, Waltham (V.R…
ORCID-Profile: Corey Cutler, Vedran Radojcic
Zitieren
APA
Wolff, D., Cutler, C., Lee, S. J., Pusic, I., Bittencourt, H., White, J., Hamadani, M., Arai, S., Salhotra, A., Perez-Simon, J. A., Alousi, A., Choe, H., Kwon, M., Bermúdez, A., Kim, I., Socié, G., Chhabra, S., Radojcic, V., O'Toole, T., …, & AGAVE-201 Investigators (2024). Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. New England Journal of Medicine, 391(11), 1002-1014. https://doi.org/10.1056/nejmoa2401537
Vancouver
Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, et al. Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. New England Journal of Medicine. 2024;391(11):1002-1014. doi:10.1056/nejmoa2401537
BibTeX
@article{Wolff2024,
author = {Wolff, Daniel and Cutler, Corey and Lee, Stephanie J and Pusic, Iskra and Bittencourt, Henrique and White, Jennifer and Hamadani, Mehdi and Arai, Sally and Salhotra, Amandeep and Perez-Simon, Jose A and Alousi, Amin and Choe, Hannah and Kwon, Mi and Bermúdez, Arancha and Kim, Inho and Socié, Gerard and Chhabra, Saurabh and Radojcic, Vedran and O'Toole, Timothy and Tian, Chuan and Ordentlich, Peter and DeFilipp, Zachariah and Kitko, Carrie L and AGAVE-201 Investigators, AGAVE-201 Investigators},
title = {Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {11},
pages = {1002--1014},
doi = {10.1056/nejmoa2401537}
}
EUVIMED